CPH Group (CPHN) Fair Value & Analysis
Basic Materials · CH · Market cap CHF 342M
Fair value as of: Jul 20, 2026
From 24 valuation models · updated 21 days ago
Share price +6.0% over the past month.
A solid business, but screening 18% overvalued on our models.
What matters now
- Solid but not exceptional quality (67/100) and above fair value, neither a clear bargain nor a standout compounder.
- A fairly wide model range (CHF 34.34 to CHF 66.28) leaves room in how you read the outcome.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 20, 2026.
How to read this chart
60‑month range CHF 36.77 – CHF 78.62 · fair‑value band CHF 34.34 – CHF 66.28 · the CHF 60.40 price screens above the CHF 49.64 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 20, 2026.
Analysis
CPH Group (CPHN) currently trades at CHF 60.40, while our model-based Fair Value estimate is CHF 49.64, implying the stock looks roughly 17.8% overvalued today. The Quality Score stands at 67/100 (solid quality), in the Basic Materials sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium, the entry price still matters most (evidence: high).
Over the trailing twelve months, CPH Group generated revenue of CHF 334M at a net margin of 7.0%. Revenue grew 8.0% year over year. It earns a return on equity of 11.3%. Net debt stands at CHF 26.2M. Fundamentals as of Jul 20, 2026
Our scenario range runs from CHF 34.34 (bear case) to CHF 66.28 (bull case); at CHF 60.40, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 22% below its 52-week high and 11% above its 52-week low, currently below its 200-day average. For context, the median of 10 Basic Materials peers we cover trades at 10% fair-value upside, at -18%, CPHN screens richer than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 24 models by family
Widest divergence: Multiples (CHF 66.24) versus Dividend Discount (CHF 16.76). Highest evidence: Growth DCF (80).
Notify me when CPHN reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 20, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 64 · Market factors (momentum, volatility) 46
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
CPH Group AG, together with its subsidiaries, develops, manufactures, and distributes chemical products and packaging solutions for pharmaceutical customers in Europe, Asia, and North and South America. It operates through two segments: Zeochem and Perlen Packaging.
Full company description
CPH Group AG, together with its subsidiaries, develops, manufactures, and distributes chemical products and packaging solutions for pharmaceutical customers in Europe, Asia, and North and South America. It operates through two segments: Zeochem and Perlen Packaging. The Zeochem segment produces molecular sieves for industrial and medical applications, chromatography gels for the pharmaceutical industry, and deuterated products used in analytics, pharmaceuticals, and OLED displays. This segment also operates production facilities in Switzerland, Bosnia and Herzegovina, the USA, Canada, China, and India. The Perlen Packaging segment focuses on the pharmaceutical industry, supplying coated plastic films used primarily in blister packaging to protect medications, as well as vials and containers for medical use; and PVC mono films and coated PVdC barrier films for use in the pharmaceutical industry. CPH Group AG was founded in 1818 and is based in Perlen, Switzerland.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
CPH Group reported revenue of CHF 334M in FY2025 versus CHF 497M in FY2021, a compound −9.4%/yr. Reported net income was CHF 23.4M in FY2025.
CPHN screens 18% overvalued. Compare with Klabin S.A →
Peer Group
Paper & Paper Products · 111 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Paper & Paper Products median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Paper & Paper Products stocks, each showing price versus our Fair Value estimate (as of Jul 20, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Klabin S.A KLBN11 | R$17.58 | R$3.89 | -78% |
| UPM-Kymmene Oyj UPM | €23.45 | €15.47 | -34% |
| Suzano S.A SUZB3 | R$41.70 | R$138.01 | +231% |
| Svenska Cellulosa Aktiebolaget SCA (publ) SCAB | kr 103.00 | kr 49.40 | -52% |
| Shandong Sunpaper Co 002078 | ¥14.13 | ¥17.29 | +22% |
| Holmen AB HOLMB | kr 305.40 | kr 217.72 | -29% |
| Nine Dragons Paper (Holdings) Limited 2689 | HK$7.55 | HK$8.73 | +16% |
| Empresas CMPC S.A CMPC | 1,078 CLP | 1,269 CLP | +18% |
| Xianhe Co 603733 | ¥22.05 | ¥24.32 | +10% |
| Billerud AB BILL | kr 68.70 | kr 48.60 | -29% |
Compare CPH Group with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Basic Materials stocks →
Frequently asked questions
Is CPH Group (CPHN) overvalued or undervalued?
What is the fair value of CPHN?
What is the quality score of CPHN?
What is the revenue of CPH Group (CPHN)?
What is the net profit margin of CPHN?
Does CPH Group pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track CPH Group and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.